Sylimaryna
* Vargas-Mendoza, N., Madrigal-Santillán, E., Morales-González, Á., Esquivel-Soto, J., Esquivel-Chirino, C., y González-Rubio, M. G. L., … & Morales-González, J. A. (2014). Hepatoprotective effect of silymarin. World journal of hepatology, 6(3), 144.; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959115/
** Abenavoli, L., Capasso, R., Milic, N., & Capasso, F. (2010). Milk thistle in liver diseases: past, present, future. Phytotherapy Research, 24(10), 1423-1432.; https://pubmed.ncbi.nlm.nih.gov/20564545/
*** Gillessen, A., & Schmidt, H. H. J. (2020). Silymarin as supportive treatment in liver diseases: A narrative review. Advances in therapy, 37(4), 1279-1301.; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140758/
**** Mohammadi, H., Hadi, A., Arab, A., Moradi, S., & Rouhani, M. H. (2019). Effects of silymarin supplementation on blood lipids: A systematic review and meta‐analysis of clinical trials. Phytotherapy Research, 33(4), 871-880.; https://pubmed.ncbi.nlm.nih.gov/30834633/
***** Surai, P. F. (2015). Silymarin as a natural antioxidant: an overview of the current evidence and perspectives. Antioxidants, 4(1), 204-247.; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665566/
Kwas foliowy
Fosfolipidy
* Varganova, D. L., Pavlov, C. S., Casazza, G., Nikolova, D., & Gluud, C. (2019). Essential phospholipids for people with non‐alcoholic fatty liver disease. The Cochrane Database of Systematic Reviews, 2019(4).; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447141/
** Küllenberg, D., Taylor, L. A., Schneider, M., & Massing, U. (2012). Health effects of dietary phospholipids. Lipids in health and disease, 11(1), 1-16.; https://pubmed.ncbi.nlm.nih.gov/22221489/
Dozowanie
Przechowywanie
Środki ostrożności
Bez konserwantów
Bez sztucznych barwników
Bez GMO
Bez herbicydów i innych pestycydów
Bez laktozy
Bez glutenu
37.1 Saller, R., Brignoli, R., & Melzer, J. (2008). The use of silymarin in the treatment of liver diseases. Drugs, 68(3), 393-415.
37.2 Buchman AL, Dubin M, Jenden D, Moukarzel A, Roch MH, Rice K, Gornbein J, Ament ME, Eckhert CD. Lecithin increases plasma free choline and decreases hepatic steatosis in long-term total parenteral nutrition patients. Gastroenterology. 1992 Apr;102(4 Pt 1):1363-70. PMID: 1551541.
37.3 Parchem K., Bartoszek A. (2016). Fosfolipidy oraz produkty ich hydrolizy jako żywieniowe czynniki prewencyjne w chorobach cywilizacyjnych. Postepy Hig Med Dosw (online), 2016; 70: 1343-1361 e-ISSN 1732-2693








Nie ma jeszcze żadnych opinii.